• 1
    Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271: 15981601.
  • 2
    Vincent JL, Rello J, Marshall J et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009; 302: 23232329.
  • 3
    Wisplinghoff H, Bischoff T, Tallent SM et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309317.
  • 4
    Saied T, Elkholy A, Hafez SF et al. Antimicrobial resistance in pathogens causing nosocomial bloodstream infections in university hospitals in Egypt. Am J Infect Control 2011; 39: e61e65.
  • 5
    Marra AR, Camargo LF, Pignatari AC et al. Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study. J Clin Microbiol 2011; 49: 18661871.
  • 6
    Jerassy Z, Yinnon AM, Mazouz-Cohen S et al. Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect 2006; 62: 230236.
  • 7
    GaynesR, Richards C, Edwards J et al. Feeding back surveillance data to prevent hospital-acquired infections. Emerg Infect Dis 2001; 7: 295298.
  • 8
    Haley RW. The scientific basis for using surveillance and risk factor data to reduce nosocomial infection rates. J Hosp Infect 1995; 30 (suppl): 314.
  • 9
    Mertens R, van den Berg JMJ, Veerman-Brenzikofer MLV, Kurz X, Jans B, Klanzinga N. International comparison results of infection surveillance: the Netherlands versus Belgium. Infect Control Hosp Epidemiol 1994; 15: 564580.
  • 10
    Starling CF, Couto BRMG, Pinheiro SMC. Applying the centers for disease control and national nosocomial surveillance system methods in Brazilian hospitals. Am J Infect Control 1997; 25: 303311.
  • 11
    CLSI. Principles and procedures for blood cultures: approved guideline. CLSI document M47-A, Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
  • 12
    Bryan CS. Clinical implications of positive blood cultures. Clin Microbiol Rev 1989; 2: 329353.
  • 13
    Novis DA, Dale JC, Schifma RB, Ruby SG, Walsh MK. Solitary blood cultures: a College of American Pathologists Q-probes study of 132,778 blood culture sets in 333 small hospitals. Arch Pathol Lab Med 2001; 125: 12901294.
  • 14
    Schifman RB, Bachner P, Howanitz PJ. Blood culture quality improvement: a College of American Pathologists Q-Probes study involving 909 institutions and 289,572 blood culture sets. Arch Pathol Lab Med 1996; 120: 9991002.
  • 15
    Suetens C, Morales I, Savey A et al. European surveillance of ICU-acquired infections (HELICS-ICU): methods and main results. J Hosp Infect 2007; 65: 171173.
  • 16
    European Antibiotic Resistance Surveillance System. EARSS Annual Report 2005. Bilthoven: EARRS, 2006.
  • 17
    Nosocomial Infection National Surveillance Service. Surveillance of hospital-acquired bacteraemia in English hospitals 1997–2002. London: Health Protection Agency, 2002.
  • 18
    Johnson AP, Davies J, Guy R, Abernethy J et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother 2012; 67: 820829.
  • 19
    Cao B, Wang H, Sun H, Zhu Y, Chen M. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. J Hosp Infect 2004; 57: 112118.
  • 20
    Johnson JR, Urban C, Weissman SJ et al. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother 2012; 56: 23642370.
  • 21
    Peirano G, Pitout JD. Molecular epidemiology Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010; 35: 316321.
  • 22
    Matsumura Y, Yamamoto M, Nagao M et al. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 2012; 67: 26122620.
  • 23
    Lark RL, Chenoweth C, Saint S et al. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2000; 38: 131140.
  • 24
    Kim YK, Pai H, Lee HJ et al. Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother 2002; 46: 14811491.
  • 25
    Peña C, Suarez C, Gozalo M et al. Prospective multicenter study of the impact of carbapenem resistance on mortality in Pseudomonas aeruginosa bloodstream infections. Antimicrob Agents Chemother 2012; 56: 12651272.